Table 1.
Demographic and clinical features of RSV-positive adult inpatients
| Category | Overall (n = 1565) | RSV-A (n = 415) | RSV-B (n = 527) |
|---|---|---|---|
| Age at Admission, median (SD) | |||
| 64.0 (18.1) | 62.0 (17.5) | 63.0 (17.7) | |
| Race, n (%) | |||
| White | 876 (56.0) | 213 (51.3) | 276 (52.4) |
| Black or African American | 457 (29.2) | 124 (29.9) | 169 (32.1) |
| Asian | 56 (3.6) | 14 (3.4) | 12 (2.3) |
| Other | 127 (8.1) | 46 (11.1) | 51 (9.7) |
| Declined or Unable to Answer | 49 (3.1) | 18 (4.3) | 19 (3.6) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 167 (10.7) | 43 (10.4) | 46 (8.7) |
| Not Hispanic or Latino | 1344 (85.9) | 354 (85.3) | 463 (87.9) |
| Declined or Unable to Respond | 54 (3.5) | 18 (4.3) | 18 (3.4) |
| Gender, n (%) | |||
| Female | 898 (57.4) | 247 (59.5) | 294 (55.8) |
| Male | 667 (42.6) | 168 (40.5) | 233 (44.2) |
| Body Mass Index (BMI), mean (SD) | |||
| 29.2 (9.8) | 29.8 (9.5) | 28.9 (8.6) | |
| Intensive Care Unit (ICU) Admission, n (%) | |||
| 415 (26.5) | 136 (32.8) | 143 (27.1) | |
| RSV Attributable Death, n (%) | |||
| 93 (5.9) | 21 (5.1) | 33 (6.3) | |
| RSV Subtype, n (%) | |||
| A | 415 (26.5) | 415 (100.0) | 0 (0.0) |
| B | 527 (33.7) | 0 (0.0) | 527 (100.0) |
| Unknown | 623 (39.8) | 0 (0.0) | 0 (0.0) |
| Comorbidities, n (%)a | |||
| Solid Organ Transplant | 94 (6.0) | 25 (6.0) | 36 (6.8) |
| Stem Cell Transplant | 134 (8.6) | 41 (9.9) | 45 (8.5) |
| Liver Disease | 279 (17.8) | 69 (16.6) | 101 (19.2) |
| Diabetes | 512 (32.7) | 149 (35.9) | 155 (29.4) |
| Renal Disease | 479 (30.6) | 137 (33.0) | 165 (31.3) |
| Cancer | 610 (39.0) | 160 (38.6) | 210 (39.8) |
| Asthma | 432 (27.6) | 132 (31.8) | 137 (26.0) |
| Coronary Artery Disease | 539 (34.4) | 149 (35.9) | 184 (34.9) |
| Hypertension | 1071 (68.4) | 292 (70.4) | 354 (67.2) |
| Immunocompromised | 201 (12.8) | 63 (15.2) | 69 (13.1) |
| Human Immunodeficiency Virus (HIV) | 74 (4.7) | 26 (6.3) | 19 (3.6) |
| Comorbidity Sum, mean (SD) | |||
| 2.8 (1.9) | 3.0 (1.8) | 2.8 (1.8) | |
| Smoking Status Upon Admission, n (%) | |||
| Current | 133 (8.5) | 25 (6.0) | 38 (7.2) |
| Former | 514 (32.8) | 123 (29.6) | 170 (32.3) |
| Never | 635 (40.6) | 174 (41.9) | 194 (36.8) |
| Unknown | 283 (18.1) | 93 (22.4) | 125 (23.7) |
Continuous variables are presented as median or mean and standard deviation (SD); categorical variables are presented as n (%). The subset of total inpatients (n = 1565) with known genotyping information for RSV-A (n = 415) and RSV-B (n = 527) are presented in adjacent columns for comparison.
aComorbidities are not mutually exclusive variables.